All data are based on the daily closing price as of November 14, 2024
o
Olympus
7733.TSE
16.10 USD
-0.14
-0.86%
Overview
Last close
16.10 usd
Market cap
18.30B usd
52 week high
19.70 usd
52 week low
12.20 usd
Target price
19.61 usd
Valuation
P/E
33.9034
Forward P/E
31.746
Price/Sales
2.9453
Price/Book Value
4.1392
Enterprise Value
18.47B usd
EV/Revenue
2.9437
EV/EBITDA
16.0255
Key financials
Revenue TTM
6.27B usd
Gross Profit TTM
3.83B usd
EBITDA TTM
1.60B usd
Earnings per Share
0.48 usd
Dividend
0.12 usd
Total assets
9.59B usd
Net debt
-2.72M usd
About
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials, such as synthetic bone filler, and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.